Aethlon Medical (AEMD) vs NeuroOne Medical Technologies (NMTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
NeuroOne Medical Technologies is the larger company by market cap ($9.8 million vs $9.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AEMD | NMTC |
|---|---|---|
| Share price | $6.01 | $1.08 |
| Market cap | $9.64M | $9.83M |
| 1-day change | -0.99% | -2.70% |
| YTD return | — | -76.25% |
| 1-year return | — | -82.69% |
| 5-year return | — | -94.00% |
| EPS (TTM) | $-32.97 | $-0.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $37.00 | $6.42 |
| 52-week low | $1.41 | $0.962 |
| Distance from 52-week high | -83.76% | -83.18% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +120.47% | +573.15% |
| Average volume | 2.56M | 339.60K |
| Shares outstanding | 1.60M | 9.11M |
| Employees | 9 | 18 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aethlon Medical
AEMD stock →Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states.
Healthcare · Medical Devices · 9 employees
About NeuroOne Medical Technologies
NMTC stock →NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
Healthcare · Medical Devices · 18 employees
AEMD vs NMTC FAQ
Which is bigger, Aethlon Medical or NeuroOne Medical Technologies?
NeuroOne Medical Technologies (NMTC) is larger, with a market capitalization of $9.83M compared with $9.64M for Aethlon Medical (AEMD).
Are Aethlon Medical and NeuroOne Medical Technologies in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.